Autologous Platelet-Rich Plasma Cream for Photoaging and Chronological Skin Aging
NCT ID: NCT02303496
Last Updated: 2014-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
20 participants
INTERVENTIONAL
2014-12-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fibroblasts have a key role on skin aging. It is known that platelet rich plasma activates the fibroblasts and increases the synthesis of collagen and other type of matrix components. Because of these specialities, platelet rich plasma is thought to be effective on skin aging.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP Cream Application
Application of Cream Containing Platelet Rich Plasma and Oleaginous Base
Platelet Rich Plasma Cream
Cream Containing Platelet Rich Plasma and Oleaginous Base
SW Cream Application - Placebo
Application of Cream Containing Sterile Water and Oleaginous Base
Placebo - Sterile Water Cream
Cream Containing Sterile Water and Oleaginous Base
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet Rich Plasma Cream
Cream Containing Platelet Rich Plasma and Oleaginous Base
Placebo - Sterile Water Cream
Cream Containing Sterile Water and Oleaginous Base
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with inflammatory skin disease like rosacea, psoriasis, seborrheic eczema
* Patients with connective tissue disease like lupus erythematosus
* Patients have a cosmetic intervention to their face, like chemical peel, infrared, radio frequency, laser, fillers or botulinum toxin injections in last 6 months
* Patients who use an anti aging cream containing retinoic acid, vitamin C and peptides in last 3 months
* Pregnant or lactating females
35 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ercument Ovali
Specialist, Haematology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acibadem Labcell
Istanbul, Fahrettin Kerim Gokay Saint No:49, Turkey (Türkiye)
Acibadem Kozyatagi Hospital
Istanbul, Inonu Saint No.20 Kozyatagi, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRP-CREAM-1
Identifier Type: -
Identifier Source: org_study_id